Ruplizumab

Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research.
Read more
€0.00 (tax incl.)
Reference:
HY-P99315
Brand:
MedChemExpress 
Product Details
HY-P99315

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
COVID-19-immunoregulation
CAS
220651-94-5

Menu

Settings

Please sign in first.

Sign in